OneMedNet regains Nasdaq compliance after filing overdue quarterly reports

OneMedNet Corp

Received Nasdaq notice confirming compliance with Listing Rule 5250(c)(1) after filing Q1-Q3 2024 Form 10-Qs.
Appointed Bob Golden as interim CFO, hired Director of Business Development and VP of Marketing.
Signed agreement with Bayer's AI Innovation Platform in early December.
Raised ~$6.4M in private placements with Off the Chain Capital and Discovery Capital Management affiliate.
Adopted Bitcoin on balance sheet treasury strategy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.